Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use
NCT01223456 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 542
Last updated 2013-10-08
Summary
This post marketing surveillance study aims to monitor the safety and efficacy of ONGLYZA under conditions of actual use in patients who are diagnosed with diabetes mellitus type 2 and are prescribed ONGLYZA by their physician.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Milagros Tan, MD · AstraZeneca Philippines
-
Emmanuel Arca, MD · AstraZeneca Philippines
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- Philippines
Study Locations
More Related Trials
-
A Study of LY2599506 in Patients With Type 2 Diabetes
NCT01024244 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes
NCT01572649 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
NCT03713684 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus
NCT01029795 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes
NCT00481117 ·Status: COMPLETED ·Phase: PHASE1
-
GALLANT 7 Tesaglitazar Add-on to Sulphonylurea
NCT00251940 ·Status: TERMINATED ·Phase: PHASE3
-
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
NCT00975286 ·Status: COMPLETED ·Phase: PHASE3
-
A Study for Patients With Type 2 Diabetes Mellitus
NCT00804986 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin
NCT01632163 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus
NCT01005069 ·Status: COMPLETED ·Phase: PHASE2
-
Linagliptin as Add on to Basal Insulin in the Elderly
NCT02240680 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
NCT02020616 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of LY3502970 in Participants With Type 2 Diabetes
NCT04426474 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
NCT04450394 ·Status: COMPLETED ·Phase: PHASE2
-
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
NCT00715624 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY2922083 in Healthy Participants and Participants With Diabetes
NCT01748552 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
NCT01169779 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3305677 in Participants With Type 2 Diabetes
NCT03928379 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY2608204 in Patients With Type 2 Diabetes
NCT01247363 ·Status: COMPLETED ·Phase: PHASE1
-
In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
NCT00354536 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3437943 in Participants With Type 2 Diabetes
NCT04867785 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
NCT04143802 ·Status: COMPLETED ·Phase: PHASE1
-
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
NCT02268214 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
NCT00655200 ·Status: COMPLETED
-
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
NCT02725593 ·Status: COMPLETED ·Phase: PHASE3